Kevin Talbot

25.8k total citations · 1 hit paper
240 papers, 12.5k citations indexed

About

Kevin Talbot is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Kevin Talbot has authored 240 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Neurology, 123 papers in Genetics and 100 papers in Molecular Biology. Recurrent topics in Kevin Talbot's work include Amyotrophic Lateral Sclerosis Research (146 papers), Neurogenetic and Muscular Disorders Research (122 papers) and Parkinson's Disease Mechanisms and Treatments (55 papers). Kevin Talbot is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (146 papers), Neurogenetic and Muscular Disorders Research (122 papers) and Parkinson's Disease Mechanisms and Treatments (55 papers). Kevin Talbot collaborates with scholars based in United Kingdom, United States and Australia. Kevin Talbot's co-authors include Martin R. Turner, Thomas H. Gillingwater, Bradley J. Turner, Olaf Ansorge, Elizabeth Gray, Lyndsay M. Murray, Matthew C. Kiernan, Alexander G. Thompson, Steven Knight and Dirk Bäumer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Kevin Talbot

231 papers receiving 12.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurofilament light chain

2015 390 citations Ching‐Hua Lu, Corrie Macdonald‐Wallis et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Talbot United Kingdom	66	6.9k	5.3k	5.0k	2.1k	1.5k	240	12.5k
Vincenzo Silani Italy	55	7.8k 1.1×	4.4k 0.8×	4.5k 0.9×	3.1k 1.5×	1.5k 1.0×	369	12.9k
Leonard H. van den Berg Netherlands	62	8.9k 1.3×	3.3k 0.6×	4.3k 0.9×	2.7k 1.3×	1.7k 1.1×	260	12.9k
Hiroshi Mitsumoto United States	62	10.1k 1.5×	4.0k 0.8×	6.0k 1.2×	2.4k 1.2×	1.7k 1.2×	252	15.2k
Masahisa Katsuno Japan	56	4.9k 0.7×	5.9k 1.1×	2.6k 0.5×	4.0k 1.9×	1.8k 1.2×	419	11.6k
Steve Vucic Australia	57	9.9k 1.4×	2.4k 0.5×	4.6k 0.9×	2.5k 1.2×	1.4k 0.9×	311	13.3k
Martin R. Turner United Kingdom	63	10.7k 1.6×	3.1k 0.6×	4.9k 1.0×	2.0k 1.0×	2.2k 1.5×	262	14.2k
Akiyoshi Kakita Japan	56	5.4k 0.8×	4.2k 0.8×	1.6k 0.3×	3.0k 1.4×	2.2k 1.5×	439	12.3k
Siddharthan Chandran United Kingdom	47	3.4k 0.5×	4.4k 0.8×	2.3k 0.5×	1.6k 0.8×	1.1k 0.8×	204	9.0k
Dirk Troost Netherlands	59	3.0k 0.4×	4.4k 0.8×	2.9k 0.6×	2.5k 1.2×	1.6k 1.1×	197	11.3k
Daniel Offen Israel	59	2.5k 0.4×	5.4k 1.0×	2.0k 0.4×	3.1k 1.5×	1.4k 0.9×	211	11.5k

Countries citing papers authored by Kevin Talbot

Since Specialization

Citations

This map shows the geographic impact of Kevin Talbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Talbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Talbot more than expected).

Fields of papers citing papers by Kevin Talbot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Talbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Talbot. The network helps show where Kevin Talbot may publish in the future.

Co-authorship network of co-authors of Kevin Talbot

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Talbot. A scholar is included among the top collaborators of Kevin Talbot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Talbot. Kevin Talbot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carroll, Emily, Jakub Scaber, K. Huber, et al.. (2025). Drug repurposing in amyotrophic lateral sclerosis (ALS). Expert Opinion on Drug Discovery. 20(4). 447–464. 2 indexed citations

Dellar, Elizabeth R., Iolanda Vendrell, David Lester, et al.. (2024). Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers. Annals of Neurology. 97(3). 449–459. 1 indexed citations

Talbot, Kevin, et al.. (2024). Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosis. BioEssays. 46(7). e2400054–e2400054. 2 indexed citations

Vahsen, Björn F., Lucy Farrimond, Emily Carroll, et al.. (2023). C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9. Nature Communications. 14(1). 5898–5898. 34 indexed citations

Gao, Jiali, Thanuja Dharmadasa, Andrea Malaspina, et al.. (2022). Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis. Journal of Neurology. 269(10). 5395–5404. 11 indexed citations

Ababneh, Nidaa A., Jakub Scaber, Rowan Flynn, et al.. (2020). Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair. Human Molecular Genetics. 29(13). 2200–2217. 52 indexed citations

Lavrov, Arseniy, Luis Garcia‐Gancedo, Jim Parr, et al.. (2020). The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 21(7-8). 563–573. 17 indexed citations

Garcia‐Gancedo, Luis, Arseniy Lavrov, Jim Parr, et al.. (2019). Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study. JMIR mhealth and uhealth. 7(12). e13433–e13433. 41 indexed citations

Sleigh, James N., John M. Dawes, Steven J. West, et al.. (2017). Trk receptor signaling and sensory neuron fate are perturbed in human neuropathy caused by Gars mutations. Proceedings of the National Academy of Sciences. 114(16). E3324–E3333. 57 indexed citations

10.

Lu, Ching‐Hua, Corrie Macdonald‐Wallis, Elizabeth Gray, et al.. (2015). Neurofilament light chain. Neurology. 84(22). 2247–2257. 390 indexed citations breakdown →

11.

Bäumer, Dirk, Kevin Talbot, & Martin R. Turner. (2014). Advances in motor neurone disease. Journal of the Royal Society of Medicine. 107(1). 14–21. 88 indexed citations

12.

Stagg, Charlotte J., Steven Knight, Kevin Talbot, et al.. (2013). Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS. Neurology. 80(7). 610–615. 42 indexed citations

13.

Turner, Martin R., Orla Hardiman, Michael Benatar, et al.. (2013). Controversies and priorities in amyotrophic lateral sclerosis. The Lancet Neurology. 12(3). 310–322. 385 indexed citations

14.

Sidey‐Gibbons, Chris, Roger Mills, Everard W. Thornton, et al.. (2011). Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). Health and Quality of Life Outcomes. 9(1). 101–101. 32 indexed citations

15.

Bäumer, Dirk, D. A. Hilton, Simon Paine, et al.. (2010). Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology. 75(7). 611–618. 148 indexed citations

16.

Parkinson, Nick, et al.. (2008). Candidate screening of the bovine and feline spinal muscular atrophy genes reveals no evidence for involvement in human motor neuron disorders. Neuromuscular Disorders. 18(5). 394–397. 5 indexed citations

17.

Ciccarelli, Olga, Timothy E.J. Behrens, Heidi Johansen‐Berg, et al.. (2008). Investigation of white matter pathology in ALS and PLS using tract‐based spatial statistics. Human Brain Mapping. 30(2). 615–624. 118 indexed citations

18.

James, Paul A., M. Zameel Cader, F. Muntoni, et al.. (2006). Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene. Neurology. 67(9). 1710–1712. 68 indexed citations

19.

Talbot, Kevin & Olaf Ansorge. (2006). Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease. Human Molecular Genetics. 15(suppl_2). R182–R187. 74 indexed citations

20.

Talbot, Kevin, Chris P. Ponting, Aspasia Theodosiou, et al.. (1997). Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism?. Human Molecular Genetics. 6(3). 497–500. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact